WallStSmart
VTAK

Catheter Precision Inc.

NYSE MKT: VTAK · HEALTHCARE · MEDICAL DEVICES

$0.94
+0.77% today

Updated 2026-04-29

Market cap
$2.51M
P/E ratio
P/S ratio
3.07x
EPS (TTM)
$-15.90
Dividend yield
52W range
$1 – $16
Volume
1.4M

Catheter Precision Inc. (VTAK) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$5.98M$5.87M$6.26M$7.20M$4.41M$22000.00$14000.00$442000.00$420000.00$819000.00
Revenue growth (YoY)-1.8%+6.6%+15.1%-38.8%-99.5%-36.4%+3057.1%-5.0%+95.0%
Cost of revenue$3.14M$4.17M$4.21M$8.85M$5.48M$1.56M$161000.00$30000.00$42000.00$63000.00
Gross profit$2.84M$1.71M$2.05M$-1.65M$-1.08M$-1.54M$-147000.00$412000.00$378000.00$756000.00
Gross margin47.5%29.0%32.8%-22.9%-24.4%-6990.9%-1050.0%93.2%90.0%92.3%
R&D$1.72M$4.52M$2.78M$4.53M$9.01M$12.25M$6.39M$475000.00$272000.00$862000.00
SG&A$30.43M$51.55M$25.97M$15.47M$2.23M$17.12M$11.35M$12.07M
Operating income$-4.20M$-17.76M$-31.16M$-57.73M$-36.06M$-29.27M$-26.96M$-78.12M$-11.24M$-12.18M
Operating margin-70.2%-302.6%-498.0%-801.9%-818.6%-133027.3%-192578.6%-17674.0%-2676.9%-1487.3%
EBITDA$-4.10M$-17.54M$-30.54M$-55.98M$-33.69M$-27.70M$-22.37M$-15.11M$-11.30M$-17.11M
EBITDA margin-68.7%-298.8%-488.0%-777.6%-764.9%-125913.6%-159771.4%-3418.6%-2691.0%-2089.0%
EBIT$-4.20M$-17.76M$-31.16M$-57.73M$-36.06M$-29.27M$-22.79M$-17.18M$-13.41M$-19.22M
Interest expense$3000.00$4000.00$14000.00$250000.00$108000.00$10000.00$3.08M$0.00$91000.00$281000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.20M$-17.77M$-30.83M$-56.96M$-36.05M$-25.07M$-26.86M$-70.57M$-16.64M$-17.18M
Net income growth (YoY)-322.8%-73.6%-84.7%+36.7%+30.4%-7.2%-162.7%+76.4%-3.2%
Profit margin-70.3%-302.6%-492.8%-791.2%-818.3%-113954.5%-191892.9%-15966.5%-3962.6%-2098.0%